A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses

DNA and Cell Biology

Volumn 26, Issue 6, 2007, Pages 435-443

  Yu, Da Hai ^a   Hu, Xi Dan ^b   Cai, Hong ^a  

^a PEKING UNIVERSITY   (China)

^b Xinjiang Academy of Animal Science   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BRUCELLA VACCINE; DNA VACCINE; GAMMA INTERFERON; GRANZYME B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PROTEIN BCSP31; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BRUCELLA ABORTUS; BRUCELLOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; L7 L12 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BASE SEQUENCE; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; CYTOKINES; DNA, BACTERIAL; FEMALE; GENES, BACTERIAL; IMMUNOGLOBULIN G; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS;

EID: 34250792187     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.0552     Document Type: Article

References (28)

1. AL DAHOUK, S., TOMASO, H., PRENGER-BERNINGHOFF, E., SPLETTSTOESSER, W.D., SCHOLZ, H.C., and NEUBAUER, H. (2005). Identification of brucella species and biotypes using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Crit Rev Microbiol 31, 191-196.
2. ALGOOD, H.M., LIN, P.L., and FLYNN, J.L. (2005). Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41 Suppl. 3, S189-S193.
3. AL-MARIRI, A., TIBOR, A., MERTENS, P., DE BOLLE, X., MICHEL, P., GODFROID, J., WALRAVENS, K., and LETESSON, J.J. (2001). Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect Immun 69, 6264-6270.
4. CAI, H., TIAN, X., HU, X.D., PAN, Y., LI, G.L., ZHUANG, Y.H., and ZHU, Y.X. (2003). Immunogenicity and protective efficacy study using combination of four tuberculosis DNA vaccines. Science in China (Series C) 46, 495-502.
5. CAI, H., TIAN, X., HU, X.D., ZHUANG, Y.H., and ZHU, Y.X. (2004). Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis. DNA Cell Biol 23, 450-456.
6. CAI, H., HU, X.D., YU, D.H., LI, S.X., TIAN, X., and ZHU, Y.X. (2005). Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. Vaccine 23, 4167-4174.
7. CARUSO, A.M., SERBINA, N., KLEIN, E., TRIEBOLD, K., BLOOM, B.R., and FLYNN, J.L. (1999). Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 162, 5407-5416.
8. CASSATARO, J., ESTEIN, S.M., PASQUEVICH, K.A., VELIKOVSKY, C.A., DE LA BARRERA, S., BOWDEN, R., FOSSATI, C.A., and GIAMBARTOLOMEI, G.H. (2005a). Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4 + T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73, 8079-8088.
9. CASSATARO, J., VELIKOVSKY, C.A., DE LA BARRERA, S., ESTEIN, S.M., BRUNO, L., BOWDEN, R., PASQUEVICH, K.A., FOSSATI, C.A., and GIAMBARTOLOMEI, G.H. (2005b). A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun 73, 6537-6546.
10. DONNELLY, J.J., WAHREN, B., and LIU, M.A. (2005). DNA vaccines: progress and challenges. J Immunol 175, 633-639.
11. GURUNATHAN, S., KLINMAN, D.M., and SEDER, R.A. (2000). DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18, 927-974.
12. KURAR, E., and SPLITTER, G.A. (1997). Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 15, 1851-1857.
13. LECLERCQ, S., HARMS, J.S., and OLIVEIRA, S.C. (2003). Enhanced efficacy of DNA vaccines against an intracellular bacterial pathogen by genetic adjuvants. Curr Pharm Biotechnol 4, 99-107.
14. MAYFIELD, J.E., BRICKER, B.J., GODFREY, H., CROSBY, R.M., KNIGHT, D.J., HALLING, S.M., BALINSKY, D., and TABATABAI, L.B. (1988). The cloning, expression and nucleotide sequence of a gene coding for an immunogenic Brucella abortus protein. Gene 63, 1-9.
15. MORIYON, I., GRILLO, M.J., MONREAL, D., GONZALEZ, D., MARIN, C., LOPEZ-GONI, I., MAINAR-JAIME, R.C., MORENO, E., and BLASCO, J.M. (2004). Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35, 1-38.
16. MUNOZ-MONTESINO, C., ANDREWS, E., RIVERS, R., GONZALEZ-SMITH, A., MORAGA-CID, G., FOLCH, H., CESPEDES, S., and ONATE, A.A. (2004). Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4 + and CD8 + T cells. Infect Immun 72, 2081-2087.
17. ONATE, A.A., CESPEDES, S., CABRERA, A., RIVERS, R., GONZALEZ, A., MUNOZ, C., FOLCH, H., and ANDREWS, E. (2003). A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 71, 4857-4861.
18. PAPPAS, G., AKRITIDIS, N., BOSILKOVSKI, M., and TSIANOS, E. (2005). Brucellosis. N Engl J Med 352, 2325-2336.
19. PUGH, G.W., JR., TABATABAI, L.B., BRICKER, B.J., MAYFIELD, J.E., PHILLIPS, M., ZEHR, E.S., and BELZER, C.A. (1990). Immunogenicity of Brucella-extracted and recombinant protein vaccines in CD-1 and BALB/c mice. Am J Vet Res 51, 1413-1420.
20. RIDGE, J.P., DI ROSA, F., and MATZINGER, P. (1998). A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell. Nature 393, 474-478.
21. SALGAME, P. (2005). Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol 17, 374-380.
22. SCHEFFOLD, A., HUHN, J., and HOFER, T. (2005). Regulation of CD4 + CD25 + regulatory T cell activity: it takes (IL-) two to tango. Eur J Immunol 35, 1336-1341.
23. SCHURIG, G.G., SRIRANGANATHAN, N., and CORBEL, M.J. (2002). Brucellosis vaccines: past, present and future. Vet Microbiol 90, 479-496.
24. SERBINA, N.V., LAZAREVIC, V., and FLYNN, J.L. (2001). CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol 167, 6991-7000.
25. SHAFER-WEAVER, K., SAYERS, T., STROBL, S., DERBY, E., ULDERICH, T., BASELER, M., and MALYGUINE, A. (2003). The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Transl Med 1, 14-22.
26. SHANG, X.Y., CHEN, H.S., ZHANG, H.G., PANG, X.W., QIAO, H., PENG, J.R., QIN, L.L., FEI, R., MEI, M.H., LENG, X.S., GNJATIC, S., RITTER, G., SIMPSON, A.J., OLD, L.J., and CHEN, W.F. (2004). The spontaneous CD8 + T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Clin Cancer Res 10, 6946-6955.
27. VAN PINXTEREN, L.A., CASSIDY, J.P., SMEDEGAARD, B.H., AGGER, E.M., and ANDERSEN, P. (2000). Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 30, 3689-3698.
28. VELIKOVSKY, C.A., CASSATARO, J., GIAMBARTOLOMEI, G.H., GOLDBAUM, F.A., ESTEIN, S., BOWDEN, R.A., BRUNO, L., FOSSATI, C.A., and SPITZ, M. (2002). A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 70, 2507-2511.